WELL Health Technologies Corp.
WELL.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.32% | 40.10% | 34.43% | 31.60% | 25.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.32% | 40.10% | 34.43% | 31.60% | 25.86% |
| Cost of Revenue | 51.46% | 62.77% | 51.32% | 46.66% | 37.23% |
| Gross Profit | 19.25% | 19.36% | 19.05% | 18.41% | 16.26% |
| SG&A Expenses | 45.87% | 51.80% | 52.80% | 21.31% | 19.40% |
| Depreciation & Amortization | 16.16% | 15.44% | 9.29% | 6.10% | 0.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.22% | 78.01% | 72.60% | 32.31% | 25.95% |
| Operating Income | 70.39% | 43.84% | 54.51% | 20.09% | 24.25% |
| Income Before Tax | 2,797.07% | 1,318.11% | 533.51% | 11.19% | 174.37% |
| Income Tax Expenses | 85.18% | -188.71% | 185.19% | 376.34% | -139.25% |
| Earnings from Continuing Operations | 1,840.79% | 1,546.21% | 336.48% | -10.72% | 157.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -73.72% | -32.58% | -9.85% | 8.83% | 45.68% |
| Net Income | 1,098.72% | 3,573.40% | 672.74% | -202.57% | 76.30% |
| EBIT | 70.39% | 43.84% | 54.51% | 20.09% | 24.25% |
| EBITDA | 57.08% | 45.49% | 45.62% | 9.49% | 5.90% |
| EPS Basic | 1,139.53% | 3,584.13% | 611.49% | 25.00% | 79.81% |
| Normalized Basic EPS | -73.80% | -76.80% | -59.22% | 8.87% | 40.44% |
| EPS Diluted | 1,067.97% | 2,889.82% | 843.68% | -88.89% | 75.96% |
| Normalized Diluted EPS | -72.11% | -75.26% | -59.22% | 8.87% | 40.44% |
| Average Basic Shares Outstanding | 4.61% | 4.73% | 5.78% | 7.20% | 8.60% |
| Average Diluted Shares Outstanding | 6.38% | 6.52% | 5.78% | 7.20% | 8.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
